Web Microsite Introduces Single Cell Gene Expression Profiling

A Web microsite introduces the rapidly expanding field of single cell gene expression profiling.

Historically, gene expression profiling of single cells, such as stem cells, circulating tumor and formalin-fixed, paraffin-embedded (FFPE) tissues has been difficult and expensive to perform. Now, however, results from single-cell samples can be obtained easily and inexpensively using the Fluidigm Corp's (South San Francisco, CA, USA) BioMark system and the company's Dynamic Array integrated fluidic circuits (IFCs). Dynamic Array IFCs are ideally suited for high-throughput cell-line studies to determine individual cell behavior in a homozygous population.

Visitors to Fluidigm Web site (see below) can gain an understanding of the technology, find out how international scientists using Fluidigm Dynamic Array chips are accelerating their research, and evaluate whether IFC technology is suitable for their project.

A five-minute audiovisual presentation provides an informative introduction to how IFC technology is now providing a practical means of studying single cells A wide selection of downloadable customer conference posters, peer-reviewed publications, success stories and application notes describe the technology in action and the benefits it is delivering to leading laboratories around the world.

Fluidigm develops, manufactures, and markets proprietary IFC systems that improve productivity in life-science research. Fluidigm's IFCs enable the simultaneous performance of thousands of sophisticated biochemical measurements in extremely minute volumes. These "integrated circuits for biology” are made possible by miniaturizing and integrating liquid-handling components on a single microfabricated microfluidic device. Fluidigm's IFC systems, consisting of instrumentation, software, and single-use IFCs, increase throughput, decrease costs, and enhance sensitivity compared to conventional laboratory systems. Fluidigm products have not been cleared or approved by the U.S. Food and Drug Administration (FDA) for use as a diagnostic and are only available for research use.

Related Links:
Fluidigm single cell analysis presentation
Fluidigm